000			02137 a2200625 4500
005			20250516054546.0
264		0	_c20120214
008			201202s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2011-06-363911 _2doi
040			_aNLM _beng _cNLM
100	1		_aNeri, Paola
245	0	0	_aBortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors. _h[electronic resource]
260			_bBlood _cDec 2011
300			_a6368-79 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBRCA1 Protein _xgenetics
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aCell Line, Tumor
650	0	4	_aCells, Cultured
650	0	4	_aDNA Repair _xdrug effects
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aPoly(ADP-ribose) Polymerase Inhibitors
650	0	4	_aProteasome Endopeptidase Complex
650	0	4	_aProteasome Inhibitors
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRad51 Recombinase _xgenetics
650	0	4	_aSurvival Analysis
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aRen, Li
700	1		_aGratton, Kathy
700	1		_aStebner, Erin
700	1		_aJohnson, Jordan
700	1		_aKlimowicz, Alexander
700	1		_aDuggan, Peter
700	1		_aTassone, Pierfrancesco
700	1		_aMansoor, Adnan
700	1		_aStewart, Douglas A
700	1		_aLonial, Sagar
700	1		_aBoise, Lawrence H
700	1		_aBahlis, Nizar J
773	0		_tBlood _gvol. 118 _gno. 24 _gp. 6368-79
856	4	0	_uhttps://doi.org/10.1182/blood-2011-06-363911 _zAvailable from publisher's website
999			_c21157275 _d21157275